VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 135 filers reported holding VIKING THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $75,000 | +13.6% | 12,000 | +9.1% | 0.01% | +50.0% |
Q2 2021 | $66,000 | -20.5% | 11,000 | -16.7% | 0.00% | -33.3% |
Q1 2021 | $83,000 | -36.6% | 13,200 | -43.2% | 0.01% | -45.5% |
Q4 2020 | $131,000 | -3.0% | 23,225 | 0.0% | 0.01% | -21.4% |
Q3 2020 | $135,000 | -19.2% | 23,225 | 0.0% | 0.01% | -39.1% |
Q2 2020 | $167,000 | +53.2% | 23,225 | 0.0% | 0.02% | +43.8% |
Q1 2020 | $109,000 | -41.4% | 23,225 | 0.0% | 0.02% | -27.3% |
Q4 2019 | $186,000 | +16.2% | 23,225 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $160,000 | -17.1% | 23,225 | 0.0% | 0.02% | -21.4% |
Q2 2019 | $193,000 | -16.5% | 23,225 | 0.0% | 0.03% | -26.3% |
Q1 2019 | $231,000 | +29.8% | 23,225 | -0.4% | 0.04% | +11.8% |
Q4 2018 | $178,000 | -40.7% | 23,325 | +35.4% | 0.03% | -47.7% |
Q3 2018 | $300,000 | +114.3% | 17,225 | +17.0% | 0.06% | +80.6% |
Q2 2018 | $140,000 | +174.5% | 14,725 | +25.6% | 0.04% | +157.1% |
Q1 2018 | $51,000 | -15.0% | 11,725 | 0.0% | 0.01% | -12.5% |
Q4 2017 | $60,000 | – | 11,725 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |